A randomized, double-blind, placebo-controlled, phase Ib clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of HW211026 ointment in patients with actinic keratosis

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 859555059aa9cbde48129447a96fd0ed48ce584f
First added on: Jan 24, 2026